Mumbai, India

Rahul Checker

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.9

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Rahul Checker in Hematopoietic Stem Cell Research

Introduction

Rahul Checker is an accomplished inventor based in Mumbai, India. He has made significant contributions to the field of hematopoietic stem cell research, holding 2 patents that focus on innovative methods for treating conditions related to stem cell deficiencies.

Latest Patents

His latest patents include a method for using jack bean lectin to increase the abundance of hematopoietic stem cells and progenitor cells in bone marrow and epidermal stem cells in the skin. This method involves administering an effective amount of jack bean lectin to subjects suffering from deficiencies in these cells. The treatment has shown promising results, leading to significant increases in the abundance of these critical cells.

Another notable patent involves a method of adjuvant treatment with chlorophyllin-containing therapeutic preparations for radioprotection during radiation therapy. This advancement aims to protect normal hematopoietic stem cells while sensitizing radio-resistant cancer cells to gamma radiation, thereby reducing the risk of radiation toxicity to normal tissues.

Career Highlights

Rahul Checker serves as the Secretary in the Department of Atomic Energy, where he applies his expertise in research and innovation. His work is pivotal in advancing medical treatments that leverage the properties of stem cells for therapeutic purposes.

Collaborations

He collaborates with notable colleagues such as Deepak Sharma and Santosh Kumar Sandur, contributing to a dynamic research environment focused on groundbreaking medical advancements.

Conclusion

Rahul Checker exemplifies the spirit of innovation in the field of hematopoietic stem cell research. His patents reflect a commitment to improving treatment options for patients with stem cell deficiencies and enhancing the efficacy of cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…